India, Oct. 14 -- Immutep Limited (IMMP), a clinical-stage biotechnology company, announced on Wednesday the receipt of a grant from the Australian Research Council (ARC) Linkage Projects scheme, worth AUD 652,248. The award was extended to the company via Monash University for joint research into the Lymphocyte Activation Gene-3.
Lymphocyte Activation Gene-3 (LAG-3) has been linked to the regulation of immune responses, including by interacting with MHC Class II proteins as a ligand. Additionally, the gene was found to have a role in the immunological synapse after a T-cell receptor interacts with an antigenic peptide.
The collaboration between Immutep and Monash University's Biomedical Discovery Institute (BDI) previously resulted in th...